Academic Journal
View in EDS
Linked Full Text

Operation Save the World from Adverse Drug Reactions: findings from a drug safety surveillance programme in Nigeria

Bibliographic Details
Title: Operation Save the World from Adverse Drug Reactions: findings from a drug safety surveillance programme in Nigeria
Authors: Yohanna Kambai Avong, MPH, Bolajoko Jatau, MPH, Gbenga Ayodele Kayode, PhD, Blessing Ukpabi, MSc, Eunice Bosede Avong, MPH, James Okuma, MS, Dennis Mordi, MSc, Alash'le Abimiku, PhD, Obinna Ogbanufe, MPH, Charles Olalekan Mensah, MBA, Patrick Dakum, MPH
Source: The Lancet Global Health, Vol 7, Iss , Pp S46- (2019)
Publisher Information: Elsevier, 2019.
Publication Year: 2019
Collection: LCC:Public aspects of medicine
Subject Terms: Public aspects of medicine, RA1-1270
More Details: Background: Adverse drug reactions are an important causes of death and account for 5–35% of hospital admissions. Operation Save the World from Adverse Drug Reactions is a drug safety surveillance programme developed in 2005 by the Institute of Human Virology Nigeria (IHVN) to address the under-reporting of adverse drug reaction in Nigeria, where millions of people use antiretroviral, anti-tuberculosis, and anti-malaria drugs. The drug safety surveillance programme runs in major public hospitals but is managed by the National Pharmacovigilance Center in collaboration with IHVN. The goal is to ensure public and global health, while the primary outcome is the reporting of adverse drug reactions to the Uppsala Monitoring Centre, through the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC). Pharmacovigilance training and the publishing of papers are secondary outcomes. Methods: The drug safety surveillance programme in Nigeria combines six key activities: collaboration between government and the private sector; the training of medical doctors, pharmacists, and nurses; establishment of pharmacovigilance centres in public hospitals; development of platforms for submitting individual case safety reports; the publishing of peer-review articles; and submission of individual case safety reports. To ensure sustainability, we collaborated with the Nigerian Government and research institutions, and trained only government health-care workers, who were randomly selected from a pool of applicants that applied to advertisements in three national newspapers. Findings: Between 2004 and 2016, Nigeria's National Pharmacovigilance Center received 16 500 individual case safety reports out of 80 000 adverse drug reaction reporting forms. The number of health-care workers who were trained in the reporting of adverse drug reactions was fewer than 300 and there was no training model during this time. However, between 2014 and 2018 when Operation Save the World from Adverse Drug Reactions was introduced and implemented, more than 5000 individual case safety reports, with more than 40 000 reactions were submitted. Furthermore, more than 3000 health-care workers have been trained in the reporting of adverse drug reactions, and a Structured Pharmacovigilance and Training Initiative (SPHARTI) model has been developed, with two peer-reviewed articles published. Serious adverse drug reactions, such as bilateral gynaecomastia, violent psychiatric disorders, and Stevens-Johnson syndrome have also been reported. Interpretation: The drug safety surveillance programme Operation Save the World from Adverse Drug Reactions has increased the reporting of adverse drug reactions in Nigeria and increased the critical mass of qualified health-care workers trained in the reporting of adverse drug reactions. The strength of the programme is in the combination of the six key activities. Challenges remain in establishing causality of the reported reactions and operating the programme at primary health centres. Funding: US PEPFAR.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2214-109X
Relation: http://www.sciencedirect.com/science/article/pii/S2214109X19301317; https://doaj.org/toc/2214-109X
DOI: 10.1016/S2214-109X(19)30131-7
Access URL: https://doaj.org/article/fd17a64aa7be45628a5a3294c033b811
Accession Number: edsdoj.fd17a64aa7be45628a5a3294c033b811
Database: Directory of Open Access Journals
FullText Links:
  – Type: other
    Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=420EA93C99115649857E&Show=Object
Text:
  Availability: 0
CustomLinks:
  – Url: https://www.doi.org/10.1016/S2214-109X(19)30131-7?
    Name: ScienceDirect (all content)-s8985755
    Category: fullText
    Text: View record from ScienceDirect
    MouseOverText: View record from ScienceDirect
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=2214109X&ISBN=&volume=7&issue=S46-&date=20190301&spage=&pages=&title=The Lancet Global Health&atitle=Operation%20Save%20the%20World%20from%20Adverse%20Drug%20Reactions%3A%20findings%20from%20a%20drug%20safety%20surveillance%20programme%20in%20Nigeria&aulast=Yohanna%20Kambai%20Avong%2C%20MPH&id=DOI:10.1016/S2214-109X(19)30131-7
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/fd17a64aa7be45628a5a3294c033b811
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.fd17a64aa7be45628a5a3294c033b811
RelevancyScore: 893
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 892.690856933594
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Operation Save the World from Adverse Drug Reactions: findings from a drug safety surveillance programme in Nigeria
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Yohanna+Kambai+Avong%2C+MPH%22">Yohanna Kambai Avong, MPH</searchLink><br /><searchLink fieldCode="AR" term="%22Bolajoko+Jatau%2C+MPH%22">Bolajoko Jatau, MPH</searchLink><br /><searchLink fieldCode="AR" term="%22Gbenga+Ayodele+Kayode%2C+PhD%22">Gbenga Ayodele Kayode, PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Blessing+Ukpabi%2C+MSc%22">Blessing Ukpabi, MSc</searchLink><br /><searchLink fieldCode="AR" term="%22Eunice+Bosede+Avong%2C+MPH%22">Eunice Bosede Avong, MPH</searchLink><br /><searchLink fieldCode="AR" term="%22James+Okuma%2C+MS%22">James Okuma, MS</searchLink><br /><searchLink fieldCode="AR" term="%22Dennis+Mordi%2C+MSc%22">Dennis Mordi, MSc</searchLink><br /><searchLink fieldCode="AR" term="%22Alash'le+Abimiku%2C+PhD%22">Alash'le Abimiku, PhD</searchLink><br /><searchLink fieldCode="AR" term="%22Obinna+Ogbanufe%2C+MPH%22">Obinna Ogbanufe, MPH</searchLink><br /><searchLink fieldCode="AR" term="%22Charles+Olalekan+Mensah%2C+MBA%22">Charles Olalekan Mensah, MBA</searchLink><br /><searchLink fieldCode="AR" term="%22Patrick+Dakum%2C+MPH%22">Patrick Dakum, MPH</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: The Lancet Global Health, Vol 7, Iss , Pp S46- (2019)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Elsevier, 2019.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2019
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Public aspects of medicine
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Public+aspects+of+medicine%22">Public aspects of medicine</searchLink><br /><searchLink fieldCode="DE" term="%22RA1-1270%22">RA1-1270</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Background: Adverse drug reactions are an important causes of death and account for 5–35% of hospital admissions. Operation Save the World from Adverse Drug Reactions is a drug safety surveillance programme developed in 2005 by the Institute of Human Virology Nigeria (IHVN) to address the under-reporting of adverse drug reaction in Nigeria, where millions of people use antiretroviral, anti-tuberculosis, and anti-malaria drugs. The drug safety surveillance programme runs in major public hospitals but is managed by the National Pharmacovigilance Center in collaboration with IHVN. The goal is to ensure public and global health, while the primary outcome is the reporting of adverse drug reactions to the Uppsala Monitoring Centre, through the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC). Pharmacovigilance training and the publishing of papers are secondary outcomes. Methods: The drug safety surveillance programme in Nigeria combines six key activities: collaboration between government and the private sector; the training of medical doctors, pharmacists, and nurses; establishment of pharmacovigilance centres in public hospitals; development of platforms for submitting individual case safety reports; the publishing of peer-review articles; and submission of individual case safety reports. To ensure sustainability, we collaborated with the Nigerian Government and research institutions, and trained only government health-care workers, who were randomly selected from a pool of applicants that applied to advertisements in three national newspapers. Findings: Between 2004 and 2016, Nigeria's National Pharmacovigilance Center received 16 500 individual case safety reports out of 80 000 adverse drug reaction reporting forms. The number of health-care workers who were trained in the reporting of adverse drug reactions was fewer than 300 and there was no training model during this time. However, between 2014 and 2018 when Operation Save the World from Adverse Drug Reactions was introduced and implemented, more than 5000 individual case safety reports, with more than 40 000 reactions were submitted. Furthermore, more than 3000 health-care workers have been trained in the reporting of adverse drug reactions, and a Structured Pharmacovigilance and Training Initiative (SPHARTI) model has been developed, with two peer-reviewed articles published. Serious adverse drug reactions, such as bilateral gynaecomastia, violent psychiatric disorders, and Stevens-Johnson syndrome have also been reported. Interpretation: The drug safety surveillance programme Operation Save the World from Adverse Drug Reactions has increased the reporting of adverse drug reactions in Nigeria and increased the critical mass of qualified health-care workers trained in the reporting of adverse drug reactions. The strength of the programme is in the combination of the six key activities. Challenges remain in establishing causality of the reported reactions and operating the programme at primary health centres. Funding: US PEPFAR.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 2214-109X
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: http://www.sciencedirect.com/science/article/pii/S2214109X19301317; https://doaj.org/toc/2214-109X
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1016/S2214-109X(19)30131-7
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/fd17a64aa7be45628a5a3294c033b811" linkWindow="_blank">https://doaj.org/article/fd17a64aa7be45628a5a3294c033b811</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.fd17a64aa7be45628a5a3294c033b811
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.fd17a64aa7be45628a5a3294c033b811
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2214-109X(19)30131-7
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: Public aspects of medicine
        Type: general
      – SubjectFull: RA1-1270
        Type: general
    Titles:
      – TitleFull: Operation Save the World from Adverse Drug Reactions: findings from a drug safety surveillance programme in Nigeria
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yohanna Kambai Avong, MPH
      – PersonEntity:
          Name:
            NameFull: Bolajoko Jatau, MPH
      – PersonEntity:
          Name:
            NameFull: Gbenga Ayodele Kayode, PhD
      – PersonEntity:
          Name:
            NameFull: Blessing Ukpabi, MSc
      – PersonEntity:
          Name:
            NameFull: Eunice Bosede Avong, MPH
      – PersonEntity:
          Name:
            NameFull: James Okuma, MS
      – PersonEntity:
          Name:
            NameFull: Dennis Mordi, MSc
      – PersonEntity:
          Name:
            NameFull: Alash'le Abimiku, PhD
      – PersonEntity:
          Name:
            NameFull: Obinna Ogbanufe, MPH
      – PersonEntity:
          Name:
            NameFull: Charles Olalekan Mensah, MBA
      – PersonEntity:
          Name:
            NameFull: Patrick Dakum, MPH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 2214109X
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: S46-
          Titles:
            – TitleFull: The Lancet Global Health
              Type: main
ResultId 1